The claim circulates constantly: "GLP-1s melt your muscle along with your fat." It's been repeated on social media, in news articles, and by fitness influencers who've never read a DXA study. Like most myths, it contains a kernel of truth surrounded by a thick shell of exaggeration.
What the Clinical Trials Actually Measured
Several GLP-1 trials included DXA (dual-energy X-ray absorptiometry) body composition substudies. The data shows that on average, approximately 25–40% of total weight lost is lean mass, with the remainder being fat mass. In the STEP 1 trial, participants lost approximately 15% of body weight, of which roughly 39% was lean mass and 61% was fat mass. SURMOUNT-1 (tirzepatide) showed similar proportions.
Is that concerning? Context matters enormously.
The Baseline Reality
Every form of weight loss — dietary restriction, bariatric surgery, medication, exercise-induced — results in some lean mass loss. This is a physiological constant, not a GLP-1-specific problem. When your body loses weight, it sheds some muscle along with fat. The relevant question isn't "does it happen?" (it does, always) but "is the ratio worse with GLP-1s than other methods?"
The answer, from available data: the lean-mass-to-fat-mass loss ratio on GLP-1 medications is comparable to what's seen with dietary restriction producing similar weight loss. It is not dramatically worse. The absolute amount of lean mass lost is larger because the total weight loss is larger — but the proportion is similar.
Bariatric surgery, for comparison, shows lean mass loss of approximately 20–30% of total weight lost — a slightly better ratio, but bariatric patients also lose more total weight, resulting in comparable absolute lean mass reduction.
A commonly cited figure is "40% muscle loss" from STEP 1. This is the lean mass proportion, not the muscle mass proportion. "Lean mass" includes water, organ tissue, and connective tissue — not just skeletal muscle. Actual skeletal muscle loss is lower than the lean mass figure suggests, though precise quantification requires MRI, which few trials have used.
What Actually Preserves Muscle
Two interventions are well-supported for mitigating lean mass loss during GLP-1 treatment: adequate protein intake (clinical recommendations range from 1.0–1.6 g/kg of body weight daily, with most practitioners suggesting a minimum of 60–100 grams per day) and resistance exercise (even modest bodyweight or band-based training sends a signal to preserve muscle).
Patients who combine GLP-1 medication with adequate protein and regular resistance training lose proportionally more fat and less lean mass than those who don't. This is consistent with decades of weight-management research — the medication changes the appetite equation, but the habits determine the composition outcome.
GLP-1 medications do not "melt muscle" any more than caloric restriction does. Lean mass loss is a normal component of any significant weight loss. The proportion on GLP-1s is comparable to other methods. The absolute amount is higher because the total weight loss is higher. Adequate protein and resistance exercise meaningfully mitigate the lean mass component. The myth persists because it's scary, shareable, and doesn't require reading actual DXA data to repeat.
Injectable semaglutide only. Physician-led, fast onboarding, custom metabolic report. HSA/FSA accepted.
Sema $99/mo, tirz $133/mo. LegitScript, 503A+503B pharmacies. Free consult, free shipping, no membership. Code x7X72r saves $25.
Injectable, oral tirzepatide, microdose. LegitScript. Flat pricing at every dose — no jumps. Commitment plans from $49/mo.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. All medications require evaluation by a licensed healthcare provider. Compounded medications are not FDA-approved. Individual results vary.